<DOC>
	<DOCNO>NCT00002177</DOCNO>
	<brief_summary>To assess magnitude duration antiviral activity plasma incidence time total suppression detectable HIV RNA plasma . To assess long-term safety tolerability combination therapy magnitude duration effect drug CD4 cell count .</brief_summary>
	<brief_title>A Pilot Open Label Trial HIV Therapy With d4T ( Stavudine ) , ddI ( Didanosine ) , Nelfinavir Hydroxyurea Subjects With Recent HIV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<criteria>Inclusion Criteria Patients must follow symptoms condition : Treatment naive . Recent HIV infection . Baseline laboratory value within acceptable range . Written , inform consent parent legal guardian patient &lt; 18 year old . Available followup least 96 week . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Documentation cause previously mention clinical condition . Intractable diarrhea . Signs symptoms bilateral peripheral neuropathy &gt; = Grade 2 . Inability tolerate oral medication . Hemophilia , bleed disorder , accessible tonsillar lymph node tissue . Patients follow prior condition exclude : History acute chronic pancreatitis . 1 . Use potent neurotoxic drug permit . No antiHIV therapy allow . Nelfinavir administer concurrently rifampin rifabutin , terfenadine ( Seldane ) , astemizole ( Hismanal ) , cisapride ( Propulsid ) , triazolam ( Halcion ) , midazolam ( Versed ) . 1 . Any prior antiretroviral therapy . Prior vaccination candidate HIV therapeutic vaccine . Previous therapy agent significant systemic myelosuppressive , neurotoxic , pancreatotoxic , hepatotoxic cytotoxic potential within 3 month study start expect need therapy time enrollment . Previous therapy rifampin rifabutin , terfenadine ( Seldane ) , astemizole ( Hismanal ) , cisapride ( Propulsid ) , triazolam ( Halcion ) , midazolam ( Versed ) within 14 day prior study entry time study . Active alcohol substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Pilot Projects</keyword>
	<keyword>HIV-1</keyword>
	<keyword>Didanosine</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Stavudine</keyword>
	<keyword>Hydroxyurea</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
</DOC>